| Barbara Debusk Eischens, RPH | |
|
1952 W Dallas Ave, Selma, AL 36701-7027 | |
| (334) 872-7211 | |
| (334) 872-7016 |
| Full Name | Barbara Debusk Eischens |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 1952 W Dallas Ave, Selma, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134512684 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 9394 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Barbara Debusk Eischens, RPH 1952 W Dallas Ave, Selma, AL 36701-7027 Ph: (334) 872-7211 | Barbara Debusk Eischens, RPH 1952 W Dallas Ave, Selma, AL 36701-7027 Ph: (334) 872-7211 |
News Archive
Medicago Inc., a clinical-stage biotechnology company focused on developing highly effective and affordable vaccines based on proprietary manufacturing technologies and Virus-Like Particles, today announced that it was included in a report of President Obama's Council of Advisors on Science and Technology entitled "Report to the President on Reengineering the Influenza Vaccine Production Enterprise to Meet the Challenges of Pandemic Influenza", which was released earlier this month. U.S. Health and Human Services Secretary Kathleen Sebelius and other public health officials held a briefing to discuss this report and the $2 billion plan to accelerate the development of drugs and vaccines to prevent the spread of infectious diseases.
Nonalcoholic fatty liver disease (NAFLD) is often caused by abdominal obesity, which is also one of the main causes of insulin resistance and metabolic syndrome. The latter, in turn, is an important cardiovascular risk factor, and has been found to be associated with the presence of carotid atherosclerotic lesions.
Health officials are growing increasingly concerned over the impact the H1N1 (swine) flu is having on populations living in Latin America, a region "which accounts for around two-thirds of the 816 confirmed deaths so far from the disease," the AFP/channelnewsasia.com reports. "The outlook is especially unsettling for the estimated 380 million people grappling with winter in South America, where the A(H1N1) virus is speedily propagating," the news service writes.
Quick-Med Technologies, Inc., a leader in developing innovative antimicrobial technologies for the healthcare and consumer markets, announced today that the U.S. Patent and Trademark Office has issued a Notice of Allowance for intellectual property that significantly adds to the current patent coverage for the Company's NIMBUS technology.
› Verified 4 days ago
Tiffany Nicole Mcilwain, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1952 W Dallas Ave, Selma, AL 36701 Phone: 334-872-7211 Fax: 334-872-7016 | |
Mrs. Angela Shelton, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1111 Highland Ave, Selma, AL 36703 Phone: 334-875-4916 | |
Mr. George Reese Ii, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1352 E Highland Ave, Selma, AL 36703 Phone: 334-872-9501 | |
Joseph E Moore, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 133 Broad St, Selma, AL 36701 Phone: 334-875-7223 Fax: 334-875-4679 | |
Mr. Kent Alan Hale, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1952 W Dallas Ave, Selma, AL 36701 Phone: 334-872-7211 Fax: 334-872-7016 | |
Mr. Hayes Palacio, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 520 Highland Ave, Selma, AL 36701 Phone: 334-322-7590 |